Tag: aspirin

Articles

• Aspirin and breast cancer
• Morphine during surgery might increase risk of metastasis

News

04/18/15

Aspirin reduces growth and self-renewal capacity of BC stem cells

08/10/14

Aspirin use is linked to improved breast cancer survival

11/21/11

Use of NSAIDs before diagnosis does not improve BC survival

04/28/11

Aspirin linked to reduced BC risk, but ibuprofen may increase it

Studies

• Acetyl salicylic acid, COX-2 inhibitors and other NSAIDs and breast cancer survival in a Finnish population-based cohort Cite
  Malin M, Murto M, Arponen O, Siltari A, Artama M, Visvanathan K, et al. Acetyl salicylic acid, COX-2 inhibitors and other NSAIDs and breast cancer survival in a Finnish population-based cohort. Authorea, Inc.; 2024; 10.22541/au.172549517.74928122/v1
• Aspirin Metabolites and Mammographic Breast Density in Premenopausal Women Cite
  Singh RK, Getz KR, Kyeyune JK, Jeon MS, Luo C, Luo J, et al. Aspirin Metabolites and Mammographic Breast Density in Premenopausal Women. Cancer Epidemiology, Biomarkers & Prevention. American Association for Cancer Research (AACR); 2024; 10.1158/1055-9965.epi-24-0017
• Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer Cite
  Chen WY, Ballman KV, Partridge AH, Hahn OM, Briccetti FM, Irvin WJ, et al. Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer. JAMA. American Medical Association (AMA); 2024; 10.1001/jama.2024.4840
• Influence of postdiagnostic aspirin use on clinical outcomes of women with breast cancer: a meta-analysis Cite
  Wu C, Hu M, Zhang S, Zhang J, Shen L, Shen X. Influence of postdiagnostic aspirin use on clinical outcomes of women with breast cancer: a meta-analysis. Women & Health. Informa UK Limited; 2023;:1-15 10.1080/03630242.2023.2293718
• Risks and benefits of salicylates in food: a narrative review Cite
  Suliburska J, Cholik RS. Risks and benefits of salicylates in food: a narrative review. Nutrition Reviews. Oxford University Press (OUP); 2023; 10.1093/nutrit/nuad136
• The role of aspirin in with breast cancer patients receiving neoadjuvant chemotherapy by targeting JAK2/ STAT3 Cite
  Zheng Y, Tang H, Zheng Q, Guan D, Mo Q. The role of aspirin in with breast cancer patients receiving neoadjuvant chemotherapy by targeting JAK2/ STAT3. Journal of Radiation Research and Applied Sciences. Elsevier BV; 2023; 16:100692 10.1016/j.jrras.2023.100692
• Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study Cite
  Löfling LL, Støer NC, Andreassen BK, Ursin G, Botteri E. Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study. Breast Cancer Research. Springer Science and Business Media LLC; 2023; 25 10.1186/s13058-023-01697-2
• Effect of Low-Dose Aspirin Versus Placebo on Incidence of Anemia in the Elderly Cite
  McQuilten ZK, Thao LTP, Pasricha S, Artz AS, Bailey M, Chan AT, et al. Effect of Low-Dose Aspirin Versus Placebo on Incidence of Anemia in the Elderly. Annals of Internal Medicine. American College of Physicians; 2023; 10.7326/m23-0675
• Low‐dose aspirin can inhibit exosomal release induced by radiotherapy in breast cancer and attenuate its inhibitory effect on NK cell proliferation Cite
  Wang L, Hu Z, Chen C, Chen T, Yao Z, Li W, et al. Low‐dose aspirin can inhibit exosomal release induced by radiotherapy in breast cancer and attenuate its inhibitory effect on NK cell proliferation. Cancer Medicine. Wiley; 2023; 10.1002/cam4.6274
• Aspirin Use and Survival Among Patients With Breast Cancer: A Systematic Review and Meta-Analysis Cite
  Baker A, Kartsonaki C. Aspirin Use and Survival Among Patients With Breast Cancer: A Systematic Review and Meta-Analysis. The Oncologist. Oxford University Press (OUP); 2023; 10.1093/oncolo/oyad186
• Prophylactic aspirin intake and breast cancer risk; A systematic review and meta-analysis of observational cohort studies Cite
  Bakierzynska M, Cullinane MC, Redmond HP, Corrigan M. Prophylactic aspirin intake and breast cancer risk; A systematic review and meta-analysis of observational cohort studies. European Journal of Surgical Oncology. Elsevier BV; 2023; 10.1016/j.ejso.2023.05.015
• Abstract 5758: Regular aspirin use, breast tumor characteristics and long-term breast cancer survival Cite
  Peng C, Holmes MD, Chen WY, Wang T, Brantley KD, Heng YJ, et al. Abstract 5758: Regular aspirin use, breast tumor characteristics and long-term breast cancer survival. Cancer Research. American Association for Cancer Research (AACR); 2023; 83:5758-5758 10.1158/1538-7445.am2023-5758
• Breast Tumor Cells Evade the Cytotoxic Action of Anastrozole, Aspirin, and Clopidogrel Cocktail Cite
  Arnachellen D, Xulu KR, Pillay K, Augustine TN. Breast Tumor Cells Evade the Cytotoxic Action of Anastrozole, Aspirin, and Clopidogrel Cocktail. Microscopy and Microanalysis. Oxford University Press (OUP); 2023; 10.1093/micmic/ozad032
• Abstract P4-03-02: Low-dose aspirin prescriptions and breast cancer recurrence: a Danish nationwide cohort study with up to 23 years of follow-up Cite
  Solmunde E, Pedersen RN, Nørgaard M, Mellemkjær L, Friis S, Ejlertsen B, et al. Abstract P4-03-02: Low-dose aspirin prescriptions and breast cancer recurrence: a Danish nationwide cohort study with up to 23 years of follow-up. Cancer Research. American Association for Cancer Research (AACR); 2023; 83:P4-03-02-P4-03-02 10.1158/1538-7445.sabcs22-p4-03-02
• Aspirin Use Is Associated With Improved Outcomes in Inflammatory Breast Cancer Patients Cite
  Johns C, Yen A, Rahimi A, Liu Y, Leitch AM, Spangler A, et al. Aspirin Use Is Associated With Improved Outcomes in Inflammatory Breast Cancer Patients. Journal of Breast Cancer. XMLink; 2023; 26 10.4048/jbc.2023.26.e3
• Benign Breast Disease, NSAIDs, and Postmenopausal Breast Cancer Risk in the CPS-II Cohort Cite
  Sherman ME, Vierkant RA, Masters M, Radisky DC, Winham SJ, Degnim AC, et al. Benign Breast Disease, NSAIDs, and Postmenopausal Breast Cancer Risk in the CPS-II Cohort. Cancer Prevention Research. American Association for Cancer Research (AACR); 2023; 10.1158/1940-6207.capr-22-0403
• Aspirin Use is Associated with Improvement in Distant Metastases Outcome in Patients with Residual Disease after Neoadjuvant Chemotherapy Cite
  Johns C, Cauble M, Liu Y, Rahimi A, Alluri P, Nwachukwu C, et al. Aspirin Use is Associated with Improvement in Distant Metastases Outcome in Patients with Residual Disease after Neoadjuvant Chemotherapy. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2022; 114:e5 10.1016/j.ijrobp.2022.07.683
• Aspirin versus placebo on estrogen levels in postmenopausal women: a double-blind randomized controlled clinical trial Cite
  Oghazian MB, Shirzad N, Ahadi M, Eivazi Adli S, Mollazadeh S, Radfar M. Aspirin versus placebo on estrogen levels in postmenopausal women: a double-blind randomized controlled clinical trial. BMC Pharmacology and Toxicology. Springer Science and Business Media LLC; 2022; 23 10.1186/s40360-022-00571-9
• The Intake of Coffee Increases the Absorption of Aspirin in Mice by Modifying Gut Microbiome Cite
  Kim J, Choi MS, Yoo HH, Kim D. The Intake of Coffee Increases the Absorption of Aspirin in Mice by Modifying Gut Microbiome. Pharmaceutics. MDPI AG; 2022; 14:746 10.3390/pharmaceutics14040746
• Abstract P3-12-01: Regular aspirin use, breast tumor characteristics and long-term breast cancer survival Cite
  Peng C, Holmes MD, Wang T, Harris A, Chen W, Brantley K, et al. Abstract P3-12-01: Regular aspirin use, breast tumor characteristics and long-term breast cancer survival. Cancer Research. American Association for Cancer Research (AACR); 2022; 82:P3-12-01-P3-12-01 10.1158/1538-7445.sabcs21-p3-12-01
• Abstract P2-11-01: Breast cancer (BC) risk among patients with benign breast disease (BBD) by NSAID use Cite
  Vierkant RA, Masters M, Teras LR, Sherman ME. Abstract P2-11-01: Breast cancer (BC) risk among patients with benign breast disease (BBD) by NSAID use. Cancer Research. American Association for Cancer Research (AACR); 2022; 82:P2-11-01-P2-11-01 10.1158/1538-7445.sabcs21-p2-11-01
• A randomized phase III, double-blinded, placebo-controlled trial of aspirin as adjuvant therapy for breast cancer (A011502): The Aspirin after Breast Cancer (ABC) Trial Cite
  Chen WY, Ballman KV, Winer EP, Openshaw TH, Hahn OM, Briccetti FM, et al. A randomized phase III, double-blinded, placebo-controlled trial of aspirin as adjuvant therapy for breast cancer (A011502): The Aspirin after Breast Cancer (ABC) Trial. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2022; 40:360922-360922 10.1200/jco.2022.40.36_suppl.360922
• Aspirin and cancer survival: a systematic review and meta-analyses of 118 observational studies of aspirin and 18 cancers Cite
  Elwood PC, Morgan G, Delon C, Protty M, Galante J, Pickering J, et al. Aspirin and cancer survival: a systematic review and meta-analyses of 118 observational studies of aspirin and 18 cancers. ecancermedicalscience. Ecancer Global Foundation; 2021; 15 10.3332/ecancer.2021.1258
• Medication use and mammographic breast density Cite
  Han Y, Lee CT, Xu S, Mi X, Phillip CR, Salazar AS, et al. Medication use and mammographic breast density. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06321-5
• Efficacy of fluvastatin and aspirin for prevention of hormonally insensitive breast cancer Cite
  Bhardwaj A, Embury MD, Rojo RD, Albarracin C, Bedrosian I. Efficacy of fluvastatin and aspirin for prevention of hormonally insensitive breast cancer. Breast Cancer Research and Treatment; 2021; 10.1007/s10549-021-06229-0
• Antiplatelet Drug Use and Breast Cancer Risk in a Prospective Cohort of Postmenopausal Women Cite
  Cairat M, Al Rahmoun M, Gunter MJ, Severi G, Dossus L, Fournier A. Antiplatelet Drug Use and Breast Cancer Risk in a Prospective Cohort of Postmenopausal Women. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2021; 30:643-652 10.1158/1055-9965.epi-20-1292
• Aspirin Use and Risk of Breast Cancer: A Meta-analysis of Observational Studies from 1989 to 2019 Cite
  Ma S, Guo C, Sun C, Han T, Zhang H, Qu G, et al. Aspirin Use and Risk of Breast Cancer: A Meta-analysis of Observational Studies from 1989 to 2019. Clinical Breast Cancer. Elsevier BV; 2021; 10.1016/j.clbc.2021.02.005
• Use of nonsteroidal anti-inflammatory drugs and breast cancer risk in a prospective cohort of postmenopausal women Cite
  Cairat M, Al Rahmoun M, Gunter MJ, Severi G, Dossus L, Fournier A. Use of nonsteroidal anti-inflammatory drugs and breast cancer risk in a prospective cohort of postmenopausal women. Breast Cancer Research. Springer Science and Business Media LLC; 2020; 22 10.1186/s13058-020-01343-1
• Aspirin might reduce the incidence of breast cancer Cite
  Cao Y, Tan A. Aspirin might reduce the incidence of breast cancer. Medicine. Ovid Technologies (Wolters Kluwer Health); 2020; 99:e21917 10.1097/md.0000000000021917
• Use of metformin and aspirin is associated with delayed cancer incidence Cite
  Sung JJ, Ho JM, Lam AS, Yau ST, Tsoi KK. Use of metformin and aspirin is associated with delayed cancer incidence. Cancer Epidemiology. Elsevier BV; 2020; 69:101808 10.1016/j.canep.2020.101808
• Aspirin use and risk of breast cancer in African American women Cite
  Bertrand KA, Bethea TN, Gerlovin H, Coogan PF, Barber L, Rosenberg L, et al. Aspirin use and risk of breast cancer in African American women. Breast Cancer Research. Springer Science and Business Media LLC; 2020; 22 10.1186/s13058-020-01335-1
• Abstract 4667: Associations between daily aspirin use and cancer risk across strata of major cancer risk factors in two large U.S. cohorts Cite
  Hurwitz LM, Michels KA, Cook MB, Pfeiffer RM, Trabert B. Abstract 4667: Associations between daily aspirin use and cancer risk across strata of major cancer risk factors in two large U.S. cohorts. Epidemiology. American Association for Cancer Research; 2020; 10.1158/1538-7445.am2020-4667
• Abstract 1441: Aspirin in combination with Letrozole or Olaparib induced apoptosis in estrogen receptor-positive T-47D & triple negative MDA-MB-231 breast cancer cell lines Cite
  Kamel MESE, Sheweita SA, Sultan AS. Abstract 1441: Aspirin in combination with Letrozole or Olaparib induced apoptosis in estrogen receptor-positive T-47D & triple negative MDA-MB-231 breast cancer cell lines. Immunology. American Association for Cancer Research; 2020; 10.1158/1538-7445.am2020-1441
• Effect of aspirin on cancer incidence and mortality in older adults Cite
  McNeil JJ, Gibbs P, Orchard SG, Lockery JE, Bernstein WB, Cao Y, et al. Effect of aspirin on cancer incidence and mortality in older adults. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2020; 10.1093/jnci/djaa114
• Abstract P5-08-06: NSAID use and breast cancer risk in a retrospective cohort of women with benign breast disease Cite
  Degnim A, Vierkant R, Winham S, Frost M, Visscher D, Carter J, et al. Abstract P5-08-06: NSAID use and breast cancer risk in a retrospective cohort of women with benign breast disease. Poster Session Abstracts. American Association for Cancer Research; 2020; 10.1158/1538-7445.sabcs19-p5-08-06
• Prediagnosis aspirin use, DNA methylation, and mortality after breast cancer: A population‐based study Cite
  Wang T, McCullough LE, White AJ, Bradshaw PT, Xu X, Cho YH, et al. Prediagnosis aspirin use, DNA methylation, and mortality after breast cancer: A population‐based study. Cancer. Wiley; 2019; 125:3836-3844 10.1002/cncr.32364
• Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study Cite
  Kehm RD, Hopper JL, John EM, Phillips K, MacInnis RJ, Dite GS, et al. Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study. Breast Cancer Research. Springer Science and Business Media LLC; 2019; 21 10.1186/s13058-019-1135-y
• Low dose aspirin blocks breast cancer-induced cognitive impairment in mice Cite
  Walker AK, Chang A, Ziegler AI, Dhillon HM, Vardy JL, Sloan EK. Low dose aspirin blocks breast cancer-induced cognitive impairment in mice. PLOS ONE. Public Library of Science (PLoS); 2018; 13:e0208593 10.1371/journal.pone.0208593
• No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study Cite
  Frisk G, Ekberg S, Lidbrink E, Eloranta S, Sund M, Fredriksson I, et al. No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study. Breast Cancer Research. Springer Science and Business Media LLC; 2018; 20 10.1186/s13058-018-1065-0
• Low-dose aspirin use and risk of contralateral breast cancer: a Danish nationwide cohort study Cite
  Bens A, Friis S, Dehlendorff C, Jensen M, Ejlertsen B, Kroman N, et al. Low-dose aspirin use and risk of contralateral breast cancer: a Danish nationwide cohort study. Preventive Medicine. Elsevier BV; 2018; 116:186-193 10.1016/j.ypmed.2018.09.015
• Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor–Treated Patients: CCTG MA.27 Cite
  Strasser-Weippl K, Higgins MJ, Chapman JW, Ingle JN, Sledge GW, Budd GT, et al. Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor–Treated Patients: CCTG MA.27. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2018; 110:1003-1008 10.1093/jnci/djy017
• The impact of aspirin use on breast cancer subtype and clinical course Cite
  Williams AD, Li YR, So A, Steel L, Carrigan E, Ro V, et al. The impact of aspirin use on breast cancer subtype and clinical course. Journal of Surgical Research. Elsevier BV; 2018; 230:71-79 10.1016/j.jss.2018.04.040
• Pre-diagnostic aspirin use and mortality after breast cancer Cite
  Wang T, Parada H, McClain KM, Bradshaw PT, Terry MB, Teitelbaum SL, et al. Pre-diagnostic aspirin use and mortality after breast cancer. Cancer Causes & Control. Springer Science and Business Media LLC; 2018; 29:417-425 10.1007/s10552-018-1020-5
• Pre-clinical effects of metformin and aspirin on the cell lines of different breast cancer subtypes Cite
  Amaral MEA, Nery LR, Leite CE, de Azevedo Junior WF, Campos MM. Pre-clinical effects of metformin and aspirin on the cell lines of different breast cancer subtypes. Investigational New Drugs. Springer Science and Business Media LLC; 2018; 36:782-796 10.1007/s10637-018-0568-y
• Aspirin and ibuprofen, in bulk and nanoforms: Effects on DNA damage in peripheral lymphocytes from breast cancer patients and healthy individuals Cite
  Dandah O, Najafzadeh M, Isreb M, Linforth R, Tait C, Baumgartner A, et al. Aspirin and ibuprofen, in bulk and nanoforms: Effects on DNA damage in peripheral lymphocytes from breast cancer patients and healthy individuals. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. Elsevier BV; 2018; 826:41-46 10.1016/j.mrgentox.2017.12.001
• Aspirin blocks cancer-associated cognitive impairment Cite
  Walker A, Sloan E. Aspirin blocks cancer-associated cognitive impairment. Brain, Behavior, and Immunity. Elsevier BV; 2017; 66:e21-e22 10.1016/j.bbi.2017.07.084
• Abstract 790: Regulation of tumor angiogenesis by low dose Aspirin Cite
  Chakraborty J, Maity G, Banerjee S, Banerjee SK. Abstract 790: Regulation of tumor angiogenesis by low dose Aspirin. Tumor Biology. American Association for Cancer Research; 2017; 10.1158/1538-7445.am2017-790
• Abstract 3012: Long-term aspirin use and total and cancer-specific mortality Cite
  Cao Y, Stampfer M, Willett W, Spiegelman D, Manson J, Rimm E, et al. Abstract 3012: Long-term aspirin use and total and cancer-specific mortality. Epidemiology. American Association for Cancer Research; 2017; 10.1158/1538-7445.am2017-3012
• Low-Dose Aspirin Reduces Breast Cancer Risk in Women with Diabetes: A Nationwide Retrospective Cohort Study in Taiwan Cite
  Yang Y, Kornelius E, Chiou J, Lai Y, Lo S, Peng C, et al. Low-Dose Aspirin Reduces Breast Cancer Risk in Women with Diabetes: A Nationwide Retrospective Cohort Study in Taiwan. Journal of Women's Health. Mary Ann Liebert Inc; 2017; 26:1278-1284 10.1089/jwh.2016.6040
• Aspirin to inhibit the formation and EMT of circulating tumor cells in patients with metastatic colorectal cancer but not breast cancer. Cite
  Ni C, Yang L. Aspirin to inhibit the formation and EMT of circulating tumor cells in patients with metastatic colorectal cancer but not breast cancer.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2017; 35:e23024-e23024 10.1200/jco.2017.35.15_suppl.e23024
• Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study Cite
  Clarke CA, Canchola AJ, Moy LM, Neuhausen SL, Chung NT, Lacey JV, et al. Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study. Breast Cancer Research. Springer Science and Business Media LLC; 2017; 19 10.1186/s13058-017-0840-7
• Aspirin regulation of c-myc and cyclinD1 proteins to overcome tamoxifen resistance in estrogen receptor-positive breast cancer cells Cite
  Cheng R, Liu Y, Cui J, Yang M, Liu X, Li P, et al. Aspirin regulation of c-myc and cyclinD1 proteins to overcome tamoxifen resistance in estrogen receptor-positive breast cancer cells. Oncotarget. Impact Journals, LLC; 2017; 8:30252-30264 10.18632/oncotarget.16325
• Aspirin as a potential modality for the chemoprevention of breast cancer: A dose-response meta-analysis of cohort studies from 857,831 participants Cite
  Lu L, Shi L, Zeng J, Wen Z. Aspirin as a potential modality for the chemoprevention of breast cancer: A dose-response meta-analysis of cohort studies from 857,831 participants. Oncotarget. Impact Journals, LLC; 2017; 8:40389-40401 10.18632/oncotarget.16315
• Sodium Salicylate Inhibits Urokinase Activity in MDA MB-231 Breast Cancer Cells Cite
  Madunić J, Horvat L, Majstorović I, Jodłowska I, Antica M, Matulić M. Sodium Salicylate Inhibits Urokinase Activity in MDA MB-231 Breast Cancer Cells. Clinical Breast Cancer. Elsevier BV; 2017; 17:629-637 10.1016/j.clbc.2017.03.015
• Low-dose aspirin use and survival in breast cancer patients: A nationwide cohort study Cite
  Mc Menamin ÚC, Cardwell CR, Hughes CM, Murray LJ. Low-dose aspirin use and survival in breast cancer patients: A nationwide cohort study. Cancer Epidemiology. Elsevier BV; 2017; 47:20-27 10.1016/j.canep.2016.12.008
• Aspirin/antiplatelet agent use improves disease-free survival and reduces the risk of distant metastases in Stage II and III triple-negative breast cancer patients Cite
  Shiao J, Thomas KM, Rahimi AS, Rao R, Yan J, Xie X, et al. Aspirin/antiplatelet agent use improves disease-free survival and reduces the risk of distant metastases in Stage II and III triple-negative breast cancer patients. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 161:463-471 10.1007/s10549-016-4081-8
• Naturally occurring dietary salicylates: A closer look at common Australian foods Cite
  Malakar S, Gibson PR, Barrett JS, Muir JG. Naturally occurring dietary salicylates: A closer look at common Australian foods. Journal of Food Composition and Analysis. Elsevier BV; 2017; 57:31-39 10.1016/j.jfca.2016.12.008
• A novel co-drug of aspirin and ursolic acid interrupts adhesion, invasion and migration of cancer cells to vascular endothelium via regulating EMT and EGFR-mediated signaling pathways: multiple targets for cancer metastasis prevention and treatment Cite
  Tang Q, Liu Y, Li T, Yang X, Zheng G, Chen H, et al. A novel co-drug of aspirin and ursolic acid interrupts adhesion, invasion and migration of cancer cells to vascular endothelium via regulating EMT and EGFR-mediated signaling pathways: multiple targets for cancer metastasis prevention and treatment. Oncotarget. Impact Journals, LLC; 2016; 7:73114-73129 10.18632/oncotarget.12232
• Aspirin use and the incidence of breast, colon, ovarian, and pancreatic cancers in elderly women in the Iowa Women’s Health Study Cite
  Vaughan LE, Prizment A, Blair CK, Thomas W, Anderson KE. Aspirin use and the incidence of breast, colon, ovarian, and pancreatic cancers in elderly women in the Iowa Women’s Health Study. Cancer Causes & Control. Springer Science and Business Media LLC; 2016; 27:1395-1402 10.1007/s10552-016-0804-8
• Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study Cite
  Dierssen-Sotos T, Gómez-Acebo I, de Pedro M, Pérez-Gómez B, Servitja S, Moreno V, et al. Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study. BMC Cancer. Springer Science and Business Media LLC; 2016; 16 10.1186/s12885-016-2692-4
• Aspirin attenuates vinorelbine-induced endothelial inflammation via modulating SIRT1/AMPK axis Cite
  Tsai K, Huang P, Kao C, Leu H, Cheng Y, Liao Y, et al. Aspirin attenuates vinorelbine-induced endothelial inflammation via modulating SIRT1/AMPK axis. Biochemical Pharmacology. Elsevier BV; 2014; 88:189-200 10.1016/j.bcp.2013.12.005
• Prediagnostic aspirin use and mortality in women with stage I to III breast cancer: A cohort study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Cite
  Bradley MC, Black A, Freedman AN, Barron TI. Prediagnostic aspirin use and mortality in women with stage I to III breast cancer: A cohort study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer. Wiley; 2016; 122:2067-2075 10.1002/cncr.30004
• Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies Cite
  Elwood PC, Morgan G, Pickering JE, Galante J, Weightman AL, Morris D, et al. Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies. PLOS ONE. Public Library of Science (PLoS); 2016; 11:e0152402 10.1371/journal.pone.0152402
• Aspirin Breaks the Crosstalk between 3T3-L1 Adipocytes and 4T1 Breast Cancer Cells by Regulating Cytokine Production Cite
  Hsieh C, Huang Y. Aspirin Breaks the Crosstalk between 3T3-L1 Adipocytes and 4T1 Breast Cancer Cells by Regulating Cytokine Production. PLOS ONE. Public Library of Science (PLoS); 2016; 11:e0147161 10.1371/journal.pone.0147161
• Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells Cite
  Talarico G, Orecchioni S, Dallaglio K, Reggiani F, Mancuso P, Calleri A, et al. Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells. Scientific Reports. Springer Science and Business Media LLC; 2016; 6 10.1038/srep18673
• Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition Cite
  Maity G, De A, Das A, Banerjee S, Sarkar S, Banerjee SK. Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition. Laboratory Investigation. Springer Science and Business Media LLC; 2015; 95:702-717 10.1038/labinvest.2015.49
• Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis Cite
  Huang X, Gao P, Sun J, Song Y, Tsai C, Liu J, et al. Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis. Cancer Causes & Control. Springer Science and Business Media LLC; 2015; 26:589-600 10.1007/s10552-015-0539-y
• Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis Cite
  de Pedro M, Baeza S, Escudero M, Dierssen-Sotos T, Gómez-Acebo I, Pollán M, et al. Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2015; 149:525-536 10.1007/s10549-015-3267-9
• Estimates of benefits and harms of prophylactic use of aspirin in the general population Cite
  Cuzick J, Thorat M, Bosetti C, Brown P, Burn J, Cook N, et al. Estimates of benefits and harms of prophylactic use of aspirin in the general population. Annals of Oncology. Elsevier BV; 2015; 26:47-57 10.1093/annonc/mdu225
• Recent Prediagnostic Aspirin Use, Lymph Node Involvement, and 5-Year Mortality in Women with Stage I–III Breast Cancer: A Nationwide Population-Based Cohort Study Cite
  Barron TI, Flahavan EM, Sharp L, Bennett K, Visvanathan K. Recent Prediagnostic Aspirin Use, Lymph Node Involvement, and 5-Year Mortality in Women with Stage I–III Breast Cancer: A Nationwide Population-Based Cohort Study. Cancer Research. American Association for Cancer Research (AACR); 2014; 74:4065-4077 10.1158/0008-5472.can-13-2679
• Use of nonsteroidal anti-inflammatory drugs and reduced breast cancer risk among overweight women Cite
  Cui Y, Deming-Halverson SL, Shrubsole MJ, Beeghly-Fadiel A, Cai H, Fair AM, et al. Use of nonsteroidal anti-inflammatory drugs and reduced breast cancer risk among overweight women. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2014; 146:439-446 10.1007/s10549-014-3030-7
• Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study Cite
  Fraser DM, Sullivan FM, Thompson AM, McCowan C. Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study. British Journal of Cancer. Springer Science and Business Media LLC; 2014; 111:623-627 10.1038/bjc.2014.264
• Aspirin intake and breast cancer survival – a nation-wide study using prospectively recorded data in Sweden Cite
  Holmes MD, Olsson H, Pawitan Y, Holm J, Lundholm C, Andersson TM, et al. Aspirin intake and breast cancer survival – a nation-wide study using prospectively recorded data in Sweden. BMC Cancer. Springer Science and Business Media LLC; 2014; 14 10.1186/1471-2407-14-391
• Post-diagnostic prescriptions for low-dose aspirin and breast cancer-specific survival: a nested case-control study in a breast cancer cohort from the UK Clinical Practice Cite
  Murray LJ, Cooper JA, Hughes CM, Powe DG, Cardwell CR. Post-diagnostic prescriptions for low-dose aspirin and breast cancer-specific survival: a nested case-control study in a breast cancer cohort from the UK Clinical Practice. Breast Cancer Research. Springer Science and Business Media LLC; 2014; 16 10.1186/bcr3638
• Aspirin-induced Bcl-2 translocation and its phosphorylation in the nucleus trigger apoptosis in breast cancer cells Cite
  Choi B, Chakraborty G, Baek K, Yoon HS. Aspirin-induced Bcl-2 translocation and its phosphorylation in the nucleus trigger apoptosis in breast cancer cells. Experimental & Molecular Medicine. Springer Science and Business Media LLC; 2013; 45:e47-e47 10.1038/emm.2013.91
• Initiation of Aspirin Therapy Modulates Angiogenic Protein Levels in Women with Breast Cancer Receiving Tamoxifen Therapy Cite
  Holmes CE, Jasielec J, Levis JE, Skelly J, Muss HB. Initiation of Aspirin Therapy Modulates Angiogenic Protein Levels in Women with Breast Cancer Receiving Tamoxifen Therapy. Clinical and Translational Science. Wiley; 2013; 6:386-390 10.1111/cts.12070
• Cyclooxygenase-2 Inhibition Blocks M2 Macrophage Differentiation and Suppresses Metastasis in Murine Breast Cancer Model Cite
  Na Y, Yoon Y, Son D, Seok S. Cyclooxygenase-2 Inhibition Blocks M2 Macrophage Differentiation and Suppresses Metastasis in Murine Breast Cancer Model. PLoS ONE. Public Library of Science (PLoS); 2013; 8:e63451 10.1371/journal.pone.0063451
• Direct regulation of caspase-3 by the transcription factor AP-2α is involved in aspirin-induced apoptosis in MDA-MB-453 breast cancer cells Cite
  YAN F, HE Q, HU X, LI W, WEI K, LI L, et al. Direct regulation of caspase-3 by the transcription factor AP-2α is involved in aspirin-induced apoptosis in MDA-MB-453 breast cancer cells. Molecular Medicine Reports. Spandidos Publications; 2013; 7:909-914 10.3892/mmr.2013.1257
• Use of Aspirin, Other Nonsteroidal Anti-Inflammatory Drugs, and Acetaminophen and Postmenopausal Breast Cancer Incidence Cite
  Zhang X, Smith-Warner SA, Collins LC, Rosner B, Willett WC, Hankinson SE. Use of Aspirin, Other Nonsteroidal Anti-Inflammatory Drugs, and Acetaminophen and Postmenopausal Breast Cancer Incidence. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2012; 30:3468-3477 10.1200/jco.2012.42.2006
• Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study Cite
  Brasky TM, Bonner MR, Moysich KB, Ambrosone CB, Nie J, Tao MH, et al. Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study. Cancer Causes & Control. Springer Science and Business Media LLC; 2010; 21:1503-1512 10.1007/s10552-010-9579-5
• NOSH-Aspirin: A Novel Nitric Oxide–Hydrogen Sulfide-Releasing Hybrid: A New Class of Anti-inflammatory Pharmaceuticals Cite
  Kodela R, Chattopadhyay M, Kashfi K. NOSH-Aspirin: A Novel Nitric Oxide–Hydrogen Sulfide-Releasing Hybrid: A New Class of Anti-inflammatory Pharmaceuticals. ACS Medicinal Chemistry Letters. American Chemical Society (ACS); 2012; 3:257-262 10.1021/ml300002m
• Use of Nonsteroidal Anti-inflammatory Drugs and Survival Following Breast Cancer Diagnosis Cite
  Li Y, Brasky TM, Nie J, Ambrosone CB, McCann SE, Shields PG, et al. Use of Nonsteroidal Anti-inflammatory Drugs and Survival Following Breast Cancer Diagnosis. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2011; 21:239-242 10.1158/1055-9965.epi-11-1012
• Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype Cite
  Brasky TM, Bonner MR, Moysich KB, Ambrosone CB, Nie J, Tao MH, et al. Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype. Cancer Causes & Control. Springer Science and Business Media LLC; 2011; 22:965-975 10.1007/s10552-011-9769-9
• Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study Cite
  Bardia A, Olson JE, Vachon CM, Lazovich D, Vierkant RA, Wang AH, et al. Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 126:149-155 10.1007/s10549-010-1074-x
• The effect of aspirin therapy on circulating vascular endothelial growth factor (VEGF) levels in tamoxifen-treated women. Cite
  Holmes CE, Jasielec J, Levis JE, Skelly J, Muss HB. The effect of aspirin therapy on circulating vascular endothelial growth factor (VEGF) levels in tamoxifen-treated women.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:679-679 10.1200/jco.2010.28.15_suppl.679
• Analgesic Use and Sex Steroid Hormone Concentrations in Postmenopausal Women Cite
  Gates MA, Tworoger SS, Eliassen AH, Missmer SA, Hankinson SE. Analgesic Use and Sex Steroid Hormone Concentrations in Postmenopausal Women. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2010; 19:1033-1041 10.1158/1055-9965.epi-09-0975
• Aspirin Intake and Survival After Breast Cancer Cite
  Holmes MD, Chen WY, Li L, Hertzmark E, Spiegelman D, Hankinson SE. Aspirin Intake and Survival After Breast Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:1467-1472 10.1200/jco.2009.22.7918
• Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health–AARP Diet and Health Study Cite
  Gierach GL, Lacey JV, Schatzkin A, Leitzmann MF, Richesson D, Hollenbeck AR, et al. Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health–AARP Diet and Health Study. Breast Cancer Research. Springer Science and Business Media LLC; 2008; 10 10.1186/bcr2089